Catalent Inc CTLT:NYSE

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 08/12/22 EDT
109.97UNCH (UNCH)
Volume
15,368
Close
109.97quote price arrow up+0.03 (+0.03%)
Volume
841,498
52 week range
86.34 - 142.64
Loading...
  • Open109.94
  • Day High110.60
  • Day Low109.01
  • Prev Close109.94
  • 52 Week High142.64
  • 52 Week High Date09/09/21
  • 52 Week Low86.34
  • 52 Week Low Date04/28/22

Key Stats

  • Market Cap19.708B
  • Shares Out179.21M
  • 10 Day Average Volume1.01M
  • Dividend-
  • Dividend Yield-
  • Beta1.29
  • YTD % Change-14.11

KEY STATS

  • Open109.94
  • Day High110.60
  • Day Low109.01
  • Prev Close109.94
  • 52 Week High142.64
  • 52 Week High Date09/09/21
  • 52 Week Low86.34
  • 52 Week Low Date04/28/22
  • Market Cap19.708B
  • Shares Out179.21M
  • 10 Day Average Volume1.01M
  • Dividend-
  • Dividend Yield-
  • Beta1.29
  • YTD % Change-14.11

RATIOS/PROFITABILITY

  • EPS (TTM)2.78
  • P/E (TTM)39.57
  • Fwd P/E (NTM)27.76
  • EBITDA (TTM)1.141B
  • ROE (TTM)11.67%
  • Revenue (TTM)4.703B
  • Gross Margin (TTM)33.83%
  • Net Margin (TTM)10.92%
  • Debt To Equity (MRQ)90.37%

EVENTS

  • Earnings Date08/29/2022
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Catalent Inc

Content From Our Affiliates

Profile

MORE
Catalent, Inc. provides delivery technologies, and development and manufacturing solutions for drugs; protein, cell, and gene therapy biologics; and consumer health products. Its segments include Softgel and Oral Technologies, Biologics, Oral and Specialty Delivery, and Clinical Supply Services. The Softgel and Oral Technologies segment is engaged in providing formulation, development, and manufacturing services for soft capsules, as well as largescale manufacturing of oral...
John Chiminski
Executive Chairman of the Board
Alessandro Maselli
President, Chief Executive Officer, Director
Thomas Castellano
Chief Financial Officer, Senior Vice President
Steven Fasman
Executive Vice President, Chief Administrative Officer, Interim General Counsel
Address
14 Schoolhouse Rd
Somerset, NJ
08873-1213
United States

Top Peers

SYMBOLLASTCHG%CHG
HZNP
Horizon Therapeutics PLC
67.47+0.37+0.55%
RPRX
Royalty Pharma PLC
44.20+0.50+1.14%
BMRN
Biomarin Pharmaceutical Inc
95.07UNCHUNCH
ELAN
Elanco Animal Health Inc
20.08+0.51+2.61%
PRGO
Perrigo Company PLC
41.87+0.22+0.53%